The role and treatment strategies of ferroptosis in liver diseases
Jia-qi WANG; Hui-yi LI; Yu-qiao HUANG; Qi-qing WENG; Gui-xiang WANG; Tian LAN.
Acta Pharmaceutica Sinica
; (12): 1604-1613, 2022.
ArtÃculo en Zh | WPRIM | ID: wpr-929447
Documentos relacionados
Identification of hyperoxidized PRDX3 as a ferroptosis marker reveals ferroptotic damage in chronic liver diseases.
Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones.
Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4.
Catalytic Degradation of Ciprofloxacin in Aqueous Solution by Peroxymonosulfate Activated with a Magnetic CuFe<sub>2</sub>O<sub>4</sub>@Biochar Composite.
High-performance, stable CoNi LDH@Ni foam composite membrane with innovative peroxymonosulfate activation for 2,4-dichlorophenol destruction.
Degradation of bisphenol A by persulfate activation of MoS<sub>2</sub> composite iron tailings.
Peroxydisulfate Activation and Singlet Oxygen Generation by Oxygen Vacancy for Degradation of Contaminants.
Molecular therapy of cardiac ischemia-reperfusion injury based on mitochondria and ferroptosis.
Enhancement of sewer sediment control and disruption of adhesive gelatinous sediment structure using low-dose calcium peroxide.
Enhanced degradation of iohexol in water by CuFe<sub>2</sub>O<sub>4</sub> activated peroxymonosulfate: Efficiency, mechanism and degradation pathway.